Domenico Salvatore

13PUBLICATIONS
23CO-AUTHORS
Haematological tumoursBiomechanicsMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 01, 2025
FT3 and FT3/FT4 ratio are decreased and not compensated by levothyroxine treatment in TKI-treated thyroid cancer patients.

Tommaso Porcelli, Cristina Luongo, Anna Cerbone

|Mar 10, 2025
Type 2 Deiodinase Promotes Fatty Adipogenesis in Muscle Fibroadipogenic Progenitors From Adult Male Mice.

Cristina Luongo, Daniela Di Girolamo, Raffaele Ambrosio

|Aug 03, 2023
D898_E901 RET Deletion Is Oncogenic, Responds to Selpercatinib, and Treatment Resistance Can Arise Via RET-Independent Mechanisms.

Tommaso Porcelli, Marialuisa Moccia, Maria Angela De Stefano

|Mar 06, 2023
Type 2 deiodinase is expressed in anaplastic thyroid carcinoma and its inhibition causes cell senescence.

Maria Angela De Stefano, Tommaso Porcelli, Raffaele Ambrosio

|Mar 04, 2023
Loss of p53 activates thyroid hormone via type 2 deiodinase and enhances DNA damage.

Annarita Nappi, Caterina Miro, Antonio Pezone

|Mar 02, 2023
Deiodinases in thyroid tumorigenesis.

Maria Angela De Stefano, Tommaso Porcelli, Martin Schlumberger

Pageof 3